发明名称 |
PROPHYLACTIC USE OF N-METHYL-D-ASPARTATE(NMDA) ANTAGONIST |
摘要 |
PURPOSE: A method for inhibiting a mammal neurological damage by administering an N-methyl-D-aspartate(NMDA) antagonist to a mammal prior to the impairment of glucose and/or oxygen supply to the brain is provided. Therefore, it inhibits a mammal neurological damage and prevents pain caused by central sensitization at the same time. CONSTITUTION: An NR2B subunit selective NMDA antagonist of a compound represented by the formula 1 in an amount effective for inhibiting a mammal neurological damage is administered to a mammal prior to the impairment of glucose and/or oxygen supply to the brain to prevent primary hyperalgesia, secondary hyperalgesia, primary allodynia, secondary allodynia, or other pain caused by central sensitization in a mammal.
|
申请公布号 |
KR20020027212(A) |
申请公布日期 |
2002.04.13 |
申请号 |
KR20010061004 |
申请日期 |
2001.09.29 |
申请人 |
PFIZER PRODUCTS INC. |
发明人 |
CHENARD BERTRAND L.;MENNITI FRANK SAMUEL;SALTARELLI MARIO D.;SCHNEIDER ERIKA |
分类号 |
C07D211/52;A61K31/00;A61K31/05;A61K31/40;A61K31/439;A61K31/445;A61K31/451;A61K31/453;A61K45/00;A61K45/06;A61P3/10;A61P9/00;A61P9/10;A61P17/02;A61P17/06;A61P19/02;A61P19/08;A61P25/00;A61P25/02;A61P25/04;A61P25/06;A61P25/08;A61P27/16;A61P29/00;A61P31/12;A61P31/18;A61P31/22;A61P35/00;A61P37/06;A61P43/00;C07D407/04;(IPC1-7):A61K31/05 |
主分类号 |
C07D211/52 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|